The common I148 M variant of PNPLA3 does not predict fibrosis progression after liver transplantation for hepatitis C

Hepatology

Volumn 54, Issue 4, 2011, Pages 1483-1484

  Do, Nicole T O ^a   Eurich, Dennis ^b   Trautwein, Christian ^a   Neuhaus, Peter ^b   Neumann, Ulf P ^a   Wasmuth, Hermann E ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PATATIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; DISEASE COURSE; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEPATITIS C; HUMAN; LETTER; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

COHORT STUDIES; DISEASE PROGRESSION; END STAGE LIVER DISEASE; FEMALE; GENETIC MARKERS; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS C, CHRONIC; HUMANS; LIPASE; LIVER TRANSPLANTATION; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECURRENCE; SENSITIVITY AND SPECIFICITY;

EID: 80053305358     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24535     Document Type: Letter

References (4)

1. Valenti L, Rumi M, Galmozzi E, Aghemo A, Del Menico B, De Nicola S, et al. Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C. HEPATOLOGY 2011; 53: 791-799.
2. Trepo E, Pradat P, Potthoff A, Momozawa Y, Quertinmont E, Gustot T, et al. Impact of PNPLA3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C. HEPATOLOGY 2011; 54: 60-69.
3. Berres ML, Trautwein C, Schmeding M, Eurich D, Tacke F, Bahra M, et al. Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection. HEPATOLOGY 2011; 53: 596-603.
4. Tarantino G, Palmiero G, Polichetti G, Perfetti A, Sabbatini M, Basile V, et al. Long-term assessment of plasma lipids in transplant recipients treated with tacrolimus in relation to fatty liver. Int J Immunopathol Pharmacol 2010; 23: 1303-1308.